Академический Документы
Профессиональный Документы
Культура Документы
DESIRED
OUTCOMES/EVALU
ATION CRITERIA—
Verbalize understanding of need for close
CLIENT WILL:
monitoring of weight, BP, urine protein, and
edema. Participate in therapeutic regimen and
monitoring, as indicated. Display Hct WNL and
physiological edema with no signs of pitting.
Page 1
NCP for Pregnancy Induced Hypertension
ACTIONS/INTERVE RATIONALE
NTIONS
Independent
Page 2
NCP for Pregnancy Induced Hypertension
Page 3
NCP for Pregnancy Induced Hypertension
Page 4
NCP for Pregnancy Induced Hypertension
Collaborative
Schedule prenatal Necessary to monitor changes more closely for
visit every 1–2 wk if the well-being of the client and fetus.
PIH is mild;
weekly if severe.
Page 5
NCP for Pregnancy Induced Hypertension
Page 6
NCP for Pregnancy Induced Hypertension
Page 7
NCP for Pregnancy Induced Hypertension
Possibly Evidenced
Variations in blood pressure/hemodynamic
By:
readings, edema, shortness of breath, change in
mental status.
ACTIONS/INTERVE RATIONALE
NTIONS:
The client with PIH does not manifest the
Independent normal cardiovascular response to pregnancy
Monitor and graph (left ventricular hypertrophy, increase in
BP and pulse. plasma volume, vascular relaxation with
decreased peripheral resistance).
Hypertension (the second
manifestation of PIH after edema) occurs
owing to increased sensitization to angiotensin
II, which increases BP, promotes aldosterone
release to increase sodium/water reabsorption
from the renal tubules, and constricts blood
vessels.
Page 8
NCP for Pregnancy Induced Hypertension
Collaborative
Monitor invasive Provides accurate picture of vascular changes
hemodynamic and fluid volume. Prolonged vascular
parameters. constriction, increased hemoconcentration, and
fluid shifts decrease cardiac output.
Administer
antihypertensive If BP does not respond to conservative
drug such as measures, short-term medication may be
hydralazine necessary in conjunction with other therapies,
(Apresoline) PO/IV, e.g., fluid replacement and MgSO4.
so that diastolic Antihypertensive drugs act directly on arterioles
readings are to promote relaxation of cardiovascular smooth
between 90 and 105 muscle and help increase blood supply to
mm Hg. Begin cerebrum, kidneys, uterus, and placenta.
maintenance therapy Hydralazine is the drug of choice because it
as needed, e.g., does not produce effects on the fetus. Sodium
methyldopa nitroprusside is being used with some success to
(Aldomet) or lower BP (especially in HELLP syndrome).
nifedipine
(Procardia).
Page 9
NCP for Pregnancy Induced Hypertension
Page 10
NCP for Pregnancy Induced Hypertension
DESIRED
OUTCOMES/EVALU Demonstrate normal CNS reactivity on
ATION CRITERIA— nonstress test (NST); be free of late
FETUS WILL: decelerations; have no decrease in FHR on
contraction stress test/oxytocin challenge test
(CST/OCT).
ACTIONS/INTERVE RATIONALE
NTIONS
Independent
Provide information
Reduced placental blood flow results in reduced
to client/couple
gas exchange and impaired nutritional
regarding home functioning of the placenta. Potential outcomes
assessment/recordin of poor placental perfusion include a
malnourished, LBW infant, and prematurity
g of daily fetal
associated with early delivery, abruptio
movements and placentae, and fetal death. Reduced fetal activity
when to seek indicates fetal compromise (occurs before
detectable
immediate
alteration in FHR and indicates need for
medical attention. immediate
evaluation/intervention.
Page 11
NCP for Pregnancy Induced Hypertension
Provide contact
number for client to Provide contact number for client to ask
ask questions, report questions, misconceptions and intervene in a
changes in daily fetal timely manner, as indicated.
movements, and so
forth.
Evaluate fetal
growth; measure Decreased placental functioning may accompany
as appropriate.
Page 12
NCP for Pregnancy Induced Hypertension
Assist with
In the event of deteriorating maternal/fetal
assessment of fetal
condition, risks of delivering a preterm infant are
maturity and
weighed against the risks of continuing the
well-being using L/S
pregnancy, using results from evaluative studies
ratio, presence of PG,
of lung and kidney maturity, fetal growth, and
estriol levels, FBM,
placental functioning. IUGR is associated with
and sequential
reduced maternal volume and vascular changes.
sonography
beginning at 20–26
weeks’ gestation.
(Refer to CP: The
High-Risk Frequency;
ND: Injury, risk for
fetal.)
Page 13
NCP for Pregnancy Induced Hypertension
Page 14
NCP for Pregnancy Induced Hypertension
DESIRED
OUTCOMES/EVALU Participate in treatment and/or environmental
ATION CRITERIA— modifications to protect self and enhance safety.
CLIENT WILL:
Be free of signs of cerebral ischemia (visual
disturbances, headache, changes in mentation).
Display normal levels of clotting factors and liver
enzymes.
ACTIONS/INTERVE RATIONALE
NTIONS
Page 15
NCP for Pregnancy Induced Hypertension
Page 16
NCP for Pregnancy Induced Hypertension
Page 17
NCP for Pregnancy Induced Hypertension
Page 18
NCP for Pregnancy Induced Hypertension
Monitor BP before,
A therapeutic level of MgSO4 is achieved with
during, and after
serum levels of 4.0–7.5 mEq/L or 6–8 mg/dL.
MgSO4
Adverse/toxic reactions develop above 10–12
administration. Note
mg/dL, with loss of DTRs occurring first,
serum magnesium
respiratory paralysis between 15–17 mg/dL, or
levels in conjunction
heart block occurring at 30–35 mg/dL.
with respiratory rate,
patellar/deep
tendon reflex (DTRs),
and urine output.
Have calcium
Serves as antidote to counteract adverse/toxic
gluconate available.
effects of MgSO4.
Administer 10 ml (1
g/10 ml) over 3 min
as indicated.
Administer
amobarbital (Amytal) Depresses cerebral activity; has sedative effect
when convulsions are not controlled by MgSO4.
or diazepem Notrecommended as first- line therapy because
(Valium), as sedativeeffect also extends to the fetus.
indicated.
Page 19
NCP for Pregnancy Induced Hypertension
Page 20
NCP for Pregnancy Induced Hypertension
ACTIONS/INTERVE RATIONALE
NTIONS
Provide information
about normal weight The underweight client may need a diet higher
in calories; the obese client should avoid dieting
gain in
pregnancy, because it places the fetus at risk for ketosis.
modifying it to meet
client’s needs.
Page 21
NCP for Pregnancy Induced Hypertension
Provide information
about effect of Reducing metabolic rate through bedrest and
bedrest and limited activity decreases protein needs.
reduced activity on
protein
requirements.
Collaborative
Refer to dietitian, as Helpful in creating individual dietary plan
indicated. incorporating specific needs/restrictions.
Page 22
NCP for Pregnancy Induced Hypertension
Page 23
NCP for Pregnancy Induced Hypertension
RATIONALE
ACTIONS/INTERVE
NTIONS
Provide information
about Helps ensure that client seeks timely treatment
signs/symptoms and may prevent worsening of preeclamptic
indicating worsening state or additional complications.
of condition, and
instruct client when
to notify healthcare
provider.
Page 24
NCP for Pregnancy Induced Hypertension
Page 25
NCP for Pregnancy Induced Hypertension
Page 26